These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22094112)

  • 21. Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy.
    Wesierska-Gadek J; Schloffer D; Kotala V; Horky M
    Int J Cancer; 2002 Sep; 101(2):128-36. PubMed ID: 12209989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16/p14ARF.
    Lang JC; Borchers J; Danahey D; Smith S; Stover DG; Agrawal A; Malone JP; Schuller DE; Weghorst CM; Holinga AJ; Lingam K; Patel CR; Esham B
    Int J Oncol; 2002 Aug; 21(2):401-8. PubMed ID: 12118338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
    Yang D; Wang JJ; Li JS; Xu QY
    Oncol Res; 2018 May; 26(4):519-528. PubMed ID: 28734041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel frameshift mutation in the p16/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16/INK4A/p14ARF locus.
    Lutful Kabir FM; Agarwal P; Deinnocentes P; Zaman J; Bird AC; Bird RC
    J Cell Biochem; 2013 Jan; 114(1):56-66. PubMed ID: 22833492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
    Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
    Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.
    Ayrault O; Andrique L; Fauvin D; Eymin B; Gazzeri S; Séité P
    Oncogene; 2006 Dec; 25(58):7577-86. PubMed ID: 16924243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
    Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligomerization of the human ARF tumor suppressor and its response to oxidative stress.
    Menéndez S; Khan Z; Coomber DW; Lane DP; Higgins M; Koufali MM; Lain S
    J Biol Chem; 2003 May; 278(21):18720-9. PubMed ID: 12582152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
    Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
    Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner.
    Kato H; Honma R; Sanda T; Fujiwara T; Ito E; Yanagisawa Y; Imai J; Okamoto T; Watanabe S
    Biochem Biophys Res Commun; 2007 Sep; 361(3):580-5. PubMed ID: 17669367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synergistic effect of 5-aza-2'-deoxycytidine and 5-fluorouracil on drug-resistant tumors.
    Morita S; Iida S; Kato K; Takagi Y; Uetake H; Sugihara K
    Oncology; 2006; 71(5-6):437-45. PubMed ID: 17690560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation.
    Eymin B; Claverie P; Salon C; Brambilla C; Brambilla E; Gazzeri S
    Cell Cycle; 2006 Apr; 5(7):759-65. PubMed ID: 16582626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p14ARF upregulation of p53 and enhanced effects of 5-fluorouracil in pancreatic cancer.
    Zhang Q; Ni Q; Gan J; Shen Z; Luo J; Jin C; Zhang N; Zhang Y
    Chin Med J (Engl); 2003 Aug; 116(8):1150-5. PubMed ID: 12935400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis.
    Schlott T; Quentin T; Korabiowska M; Budd B; Kunze E
    Int J Mol Med; 2004 Nov; 14(5):825-36. PubMed ID: 15492852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cancer stem markers could be influenced by silencing of p16 gene in HeLa cervical carcinoma cells.
    Wu H; Zhang J; Shi H
    Eur J Gynaecol Oncol; 2016; 37(2):221-5. PubMed ID: 27172749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein.
    Johansson HJ; El-Andaloussi S; Holm T; Mäe M; Jänes J; Maimets T; Langel U
    Mol Ther; 2008 Jan; 16(1):115-23. PubMed ID: 17984975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.
    Sebens Müerköster S; Rausch AV; Isberner A; Minkenberg J; Blaszczuk E; Witt M; Fölsch UR; Schmitz F; Schäfer H; Arlt A
    Oncogene; 2008 Feb; 27(8):1122-34. PubMed ID: 17704804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
    Agrawal A; Yang J; Murphy RF; Agrawal DK
    Exp Mol Pathol; 2006 Oct; 81(2):115-22. PubMed ID: 16919268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.